| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.00B | +20.3% |
| Cost of Revenue | $431.7M | +14.2% |
| Gross Profit | $568.3M | +25.3% |
| R&D Expense | $190.4M | +5.8% |
| SG&A Expense | $108.3M | +9.6% |
| Operating Income | $21.0M | +148.8% |
| Pre-tax Income | $34.2M | +208.0% |
| Income Tax | $16.3M | +957.5% |
| Net Income | $17.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $143.1M | +231.5% |
| Accounts Receivable | $99.4M | +25.3% |
| Inventory | $133.7M | +30.2% |
| Current Assets | $691.6M | +18.3% |
| Total Assets | $1.06B | +12.7% |
| Current Liabilities | $163.2M | +24.5% |
| Total Liabilities | $199.3M | +25.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $135.0M | +97.3% |
| Capital Expenditures | $19.4M | +7.6% |
| Investing Cash Flow | -$6.4M | +94.2% |
| Financing Cash Flow | -$28.4M | -236.1% |
| Free Cash Flow | $115.5M | +129.4% |
| +160.1% |
| EPS (Basic) | $0.27 | +160.0% |
| EPS (Diluted) | $0.26 | +157.8% |
| Stockholders' Equity |
| $859.2M |
| +10.0% |